Target the latest advances in genomics, proteomics and molecular sciences as predictive biomarkers and companion diagnostics for therapeutic targeting, trial stratification and population segmentation.
Leverage innovative clinical trial designs, skilled investigator networks, and advanced data sciences to accelerate critical trials for stem cell therapies, novel biologicals and pharmaceuticals, and refine or reposition drug use across key disease areas.
Draw on thousands of highly skilled research sites in over 40 countries for large-scale studies to examine therapeutic needs, disease burden, treatment options and comparative effectiveness in rigorous population-based research programs.
Monitor resource utilization and costs, define healthcare benefit and therapeutic value, and develop comprehensive budget strategies to ensure products are optimally priced for rapid market uptake and are tightly aligned with payer and provider needs in target countries.
Examine genetic profile, clinical risk factors, disease progress, current therapeutic strategies, health outcomes and economic consequences across hundreds of international sites to understand the basis of rare or complex diseases, analyze care and guide therapeutic research.
Big Data analysis
Employ high-performance statistical methods and predictive analytics to explore national and international data sets linking genomics, clinical course, health outcomes and economics to define critical relationships, uncover hidden patterns and guide future research strategies.